PELLEI, Maura
 Distribuzione geografica
Continente #
NA - Nord America 17.631
EU - Europa 6.780
AS - Asia 3.640
SA - Sud America 76
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 44
OC - Oceania 23
Totale 28.264
Nazione #
US - Stati Uniti d'America 16.952
CN - Cina 2.955
IT - Italia 2.089
DE - Germania 887
UA - Ucraina 829
CA - Canada 673
PL - Polonia 670
SE - Svezia 658
GB - Regno Unito 472
FI - Finlandia 367
FR - Francia 364
SG - Singapore 359
IE - Irlanda 183
EU - Europa 68
IN - India 61
IR - Iran 51
UY - Uruguay 50
VN - Vietnam 45
BE - Belgio 34
NL - Olanda 31
RU - Federazione Russa 31
TR - Turchia 28
CH - Svizzera 27
CZ - Repubblica Ceca 27
KR - Corea 27
PK - Pakistan 26
PT - Portogallo 26
RO - Romania 24
ES - Italia 21
AU - Australia 20
NG - Nigeria 20
JP - Giappone 19
TH - Thailandia 17
EG - Egitto 14
IQ - Iraq 12
CL - Cile 10
LT - Lituania 10
HU - Ungheria 9
MY - Malesia 9
PE - Perù 9
HK - Hong Kong 7
AM - Armenia 6
AT - Austria 6
BR - Brasile 5
MX - Messico 5
GR - Grecia 4
IL - Israele 3
JO - Giordania 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TN - Tunisia 3
CM - Camerun 2
DK - Danimarca 2
ID - Indonesia 2
MR - Mauritania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
HN - Honduras 1
LB - Libano 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SM - San Marino 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 28.264
Città #
Jacksonville 1.967
Fairfield 1.858
Woodbridge 1.853
Chandler 1.150
Houston 1.119
Ashburn 1.027
Wilmington 915
Seattle 749
Ann Arbor 706
Dearborn 705
Nanjing 630
Cambridge 581
Toronto 501
Warsaw 450
Camerino 445
Beijing 305
San Mateo 304
Princeton 288
Lawrence 287
Columbus 254
Ogden 219
Singapore 214
Boardman 213
Kraków 206
Nanchang 203
Dublin 181
Bremen 167
Helsinki 158
Shenyang 141
Lachine 134
New York 132
Kunming 128
Milan 113
Shanghai 109
Jiaxing 99
Guangzhou 94
San Diego 90
London 86
Tianjin 79
Hebei 78
Hefei 73
Jinan 71
Changsha 62
Redwood City 62
Los Angeles 60
Wuhan 54
Düsseldorf 52
Montevideo 50
Philadelphia 46
Venezia 46
Rome 45
Falls Church 44
Hangzhou 43
Orange 42
Verona 40
Zhengzhou 40
Dong Ket 38
Brussels 30
Jinhua 30
Centro 29
Lanzhou 28
Mcallen 28
Fuzhou 27
Montréal 27
Norwalk 27
Chicago 26
Ningbo 24
Leawood 23
Padova 23
Auburn Hills 21
Munich 21
Changchun 20
Washington 20
Chengdu 19
Kocaeli 18
Ardabil 17
Dallas 17
Perugia 17
Seoul 17
Taizhou 17
Tappahannock 17
Brno 16
Castelraimondo 16
Monmouth Junction 16
Shenzhen 16
Ancona 15
Bangkok 15
Indiana 15
Islamabad 15
Wuxi 15
Yiwu 15
Augusta 14
Grottammare 13
Lausanne 13
Lisbon 13
Fabriano 12
Horia 12
New Bedfont 12
Simi Valley 12
Strasbourg 12
Totale 20.616
Nome #
Additivi inorganici ritardanti di fiamma non alogenati: idrossido di magnesio naturale ed idrossido di alluminio prodotti per macinazione 429
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 253
XLIII Congresso Nazionale di Chimica Inorganica 252
null 248
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 226
Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei 213
The hydridotris(3-nitro-1,2,4-triazol-1-yl)borate, a new nitro-substituted electron withdrawing polydentate "scorpionate"-type ligand and related copper and silver phosphane complexes 209
Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6] 207
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 202
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 201
Boron-Centered Scorpionate-Type NHC-Based Ligands and Their Metal Complexes 201
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part A: pyrazole-based systems 193
Scorpionate complexes with the main group elements Ca, Ba, Sr 188
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 182
Copper(I) isocyanide and phosphane complexes of fluorinated mono- and bis-(pyrazolyl)borates 179
Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands 177
Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies 176
Solution and solid-state structural properties of silver(I) dihydrobis(pyrazolyl)borate compounds with tertiary mono(phosphine) ligands 175
Advances in Copper Complexes as Anticancer Agents 174
Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl) dithioacetate ligand 170
Chemistry and relevant biomimetic applications of group 6 metals systems supported by scorpionates 166
Synthesis, spectroscopic and structural characterization of Cu(II) derivatives of tris(pyrazol-1-yl)methanes 164
Silver(I) and copper(I) complexes supported by fully fluorinated 1,3,5-triazapentadienyl ligands 163
null 162
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part B: imidazole-, triazole- and other heterocycle-based systems 161
Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes 161
Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes 161
Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(I) complexes 159
null 159
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 159
Synthesis, in vitro and in vivo characterization of Cu-64(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands 158
Sulfonate- or carboxylate-functionalized N-heterocyclic bis-carbene ligands and related water soluble silver complexes 157
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 155
null 155
In Vitro Antitumour Activity of Water Soluble Cu(I), Ag(I) and Au(I) Complexes Supported by Hydrophilic Alkyl Phosphine Ligands 153
A Study on the Coordinative Versatility of new N,S-donor Macrocyclic Ligands: XAFS, and Cu2+ complexation thermodynamics in solution 152
Bridged poly(1-imidazolyl)borate silver(I) complexes containing tertiary mono(phosphine) ligands. The first structurally authenticated bis(imidazolyl)borate metal complex 152
In vitro antitumor activity of the water soluble copper(I) complexes bearing tris(hydroxymethyl)phosphine ligand 152
Biomimetic Applications of Metal Systems Supported by Scorpionates 151
Novel scorpionate-type triscarbene ligands and their silver and gold complexes 150
Synthesis and spectroscopic characterization of new organotin(IV) complexes with bis(3,5-dimethylpyrazol-1-yl)dithioacetate 150
A new ester substituted heteroscorpionate ligand 149
Synthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligands 149
Synthesis, spectroscopic characterization, and structural systematics of new triorganophosphinecopper(I) poly(pyrazol-1-yl)borate complexes 148
Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents 148
Oxo-rhenium(V) compounds containing bis(3,5-dimethylpyrazol-1-yl)acetate scorpionate ligand 147
Silver(I) poly(1,2,3-benzotriazolyl)borate complexes containing mono- and bidentate phosphine coligands 146
Synthesis and solution studies by electrospray mass spectroscopy of new bis(imidazolyl)borate organotin(IV) complexes 145
Copper and Silver Derivatives of Scorpionates and related Ligands 145
New (diphenylphosphane)benzoic acid copper(I) derivatives of “scorpionate” ligands with superoxide scavenging activity 143
Synthesis, characterization and antioxidant activity of new copper(I) complexes of scorpionate and water soluble phosphane ligands 143
Synthesis, Spectroscopic, and X-ray Diffraction StructuralStudies of Tin(IV) Derivatives with Tris(pyrazol-1-yl)methanes 143
The reactivity of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate (Tm) towards organotin(IV) acceptors. An unprecedented monodentate coordination mode of Tm ligand 143
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 142
Di- and tri-organotin(IV) complexes of the new bis(1-methyl-1H-imidazol-2-ylthio) acetate ligand and the decarboxylated analogues 140
Novel multicharged silver(I)–NHC complexes derived from zwitterionic 1,3-symmetrically and 1,3-unsymmetrically substituted imidazoles and benzimidazoles: Synthesis and cytotoxic properties 140
"Bio skills in motion save the world" - EARTH - Progetto Leonardo da Vinci - Virtual Job Hunt 139
New homoleptic carbene transfer ligands and related coinage metal complexes 138
Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand 138
Synthesis, characterization and hydrolytic behavior of new bis(2-pyridylthio)acetate ligand and related organotin(IV) complexes 138
Synthesis and spectroscopic characterization of new triorganotin(IV) complexes with the bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand: effects on trout erythrocyte components 138
Applications of scorpionate ligands in enzyme modeling and biological studies 137
Synthesis and characterization of new organotin(IV) complexes with polyfunctional ligands 137
XAFS studies on copper(I) complexes containing scorpionate ligands 136
Unsymmetrical 3- and 5-substituted bis(pyrazolyl)borate system 135
Copper in Diseases and Treatments, and Copper-based Anticancer Strategies 135
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 135
Synthesis and Biological Activity of Ester- and Amide-Functionalized Imidazolium Salts and Related Water-Soluble Coinage Metal N-Heterocyclic Carbene Complexes 135
Silver(I) poly(1,2,4-triazolyl)borate complexes containing monodentate phosphane ligands 132
null 132
Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and "scorpionate" ligands with "in vitro" superoxide scavenging activity 130
Silver(I)-organophosphane complexes of electron withdrawing CF3- or NO2-substituted scorpionate ligands 130
The relationship between the electrospray ionizationbehaviour and biological activity of some phosphinoCu(I) complexes 130
In vitro activity and neurotoxicity of new promising metal-based anticancer complexes 130
Silver(I)-organophosphane complexes of the dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand. X-ray crystal structure of {[H2B(tzNO2)2]Ag[P(m-tolyl)3]2} with the scorpionate ligand co-ordinated in an unidentate κ1-N fashion 130
New phosphino silver(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. X-ray crystal structure of tricyclohexylphosphine-silver(I)-hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. 128
Development of new and efficient copper(II) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidation 128
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 127
The First Nitro-Substituted Heteroscorpionate Ligand 127
Synthesis and structural investigations of novel palladium(II) and rhodium(I) complexes containing chiral ligands with a stereogenic sulfur donor, such as β-amino sulfoxides and C2-symmetric bis-sulfoxides 127
On the interaction between imidazoles and zinc salts. The role of counterions and of substituents 127
null 126
Solution and solid-state structural properties of silver(I) poly(pyrazolyl)borate compounds with bidentate diphosphines 125
11th workshop on PharmacoBioMetallics (BIOMET11) 125
Zinc(II), cadmium(II) and mercury(II) derivatives of bis(4-halopyrazol-l-yl)alkanes: synthesis, spectroscopic characterization and behaviour in solution 124
Silver(I) bis(1,2,4-triazolyl)borate complexes containing bidentate phosphine ligands. 123
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 123
Copper complexes as anticancer agents 121
On the interaction between imidazoles and cadmium salts. Comparison between cadmium and zinc complexes of imidazoles 121
null 120
Dalle fosfine ai carbeni idrosolubili: sviluppo di complessi del gruppo 11 e studi bioinorganici 120
null 120
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 120
Synthesis and characterization of the first poly(imidazolyl)borate organotin(IV) complex exhibiting a polymeric chain structure 119
Coordination chemistry of the sterically hindered N3-donor hydrotris (3,5-diphenylpyrazol-1-yl) borate toward silver(I) triorganophosphino compounds. Synthesis, structural and spectroscopic characterization 119
ISRN Inorganic Chemistry 118
Gold Derivatives of scorpionates: Comparison with other coinage metal poly(pyrazolyl)borate analogues 118
New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity 117
Realizzazione del sito web e webmaster del XLIII Congresso Nazionale di Chimica Inorganica 117
Small scorpionate ligands: Silver(I)-Organophosphane complexes of 5-CF3-Substituted scorpionate ligand combining a B-H...Ag coordination motif 116
Totale 15.337
Categoria #
all - tutte 123.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.569 0 0 662 1.111 350 837 701 701 346 374 135 352
2020/20214.561 220 394 271 374 316 332 619 113 459 146 866 451
2021/20222.914 264 787 56 71 215 121 92 232 212 322 221 321
2022/20233.513 342 39 110 487 496 506 18 230 720 176 249 140
2023/20243.118 427 168 266 101 155 325 108 201 367 92 86 822
2024/2025655 432 222 1 0 0 0 0 0 0 0 0 0
Totale 29.117